Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CRBP

Corbus Pharmaceuticals Holdings Inc

Jun 08 • 04:00PM ET

7.56

0.00 0.00 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: KPTI CAMP CNTX ELTX ENLV RNA TNXP UNCY OABI TENX

| Held by: VTI VXF DFAS IWC DFMC AVSC OZEM DFAC DFAU DCOR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.81	Insider Own	10.76%	Shs Outstand	17.74M	Perf Week	-2.45%
Market Cap	140.07M	Forward P/E	-	EPS next Y	-5.15	Insider Trans	-2.34%	Shs Float	16.53M	Perf Month	-30.45%
Enterprise Value	2.68M	PEG	-	EPS next Q	-1.26	Inst Own	60.00%	Short Float	7.23%	Perf Quarter	-20.84%
Income	-84.53M	P/S	-	EPS this Y	21.34%	Inst Trans	-1.95%	Short Ratio	2.92	Perf Half Y	-29.28%
Sales	0.00M	P/B	1.06	EPS next Y	-10.89%	ROA	-59.44%	Short Interest	1.20M	Perf YTD	-7.13%
Book/sh	7.12	P/C	1.01	EPS next 5Y	2.43%	ROE	-66.70%	52W High	20.56 -63.23%	Perf Year	-18.09%
Cash/sh	7.48	P/FCF	-	EPS past 3/5Y	16.56% 32.70%	ROIC	-66.90%	52W Low	6.72 12.50%	Perf 3Y	-18.88%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.20% 8.99%	Perf 5Y	-88.55%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-37.60%	Oper. Margin	-	ATR (14)	0.81	Perf 10Y	-92.03%
Dividend Ex-Date	-	Quick Ratio	7.92	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	37.94	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.92	EPS Q/Q	11.75%	SMA20	-18.88%	Beta	2.59	Target Price	36.50
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-22.78%	Rel Volume	0.54	Prev Close	7.56
Employees	36	LT Debt/Eq	0.00	Earnings	May 12 BMO	SMA200	-26.64%	Avg Volume	409.71K	Price	7.56
IPO	Oct 27, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.78% -	Trades		Volume	219,421	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)